BioRestorative Therapies, Inc. (BRTX)
Develops stem cell therapies to treat spine disease and obesity.
$0.27-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-81.1%
The outlook
BRTX is trading well below both its 50- and 200-day moving averages, near the bottom of its 52-week range. Analyst coverage shows a wide gap, with the average price target sitting substantially above the current price, though the overall sentiment leans bearish. The stock is highly volatile and speculative in nature.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Price targetAvg target +2901% vs current price
Analyst price target
~12-month · 2 analysts$8.00average target+2900.8% vs now
Now $0.27
Low $1.00High $15.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$6.8M
52-wk high
$1.89
52-wk low
$0.16
50-day avg
$0.34
200-day avg
$0.70
Trailing P/E
—